Interested in finding a better way to develop drugs to treat amyotrophic lateral sclerosis (ALS), Northeastern researcher ...

Combining pioneering iPSC technology and patented live cell bioimaging, LumiSTAR is opening up exciting new possibilities in the treatment of various diseases and the development of innovative new dru ...

UM researchers have developed a deep learning model to predict compound protein interactions. GraphBAN is an inductive ...

Northeastern University researchers resurrected an extinct plant gene, turning back the evolutionary clock to pave a path ...

ProFuse's novel technology addresses the growing need to preserve muscle in the face of aging and the popularity of ...

AMPLY, the company behind the proprietary AMPLYfolioAI platform, is accelerating the discovery of new medicines for complex ...

Choosing between plate reader-based assays and mass spectrometry solutions is a key decision for scientists when evaluating ...

A new company has entered the drug discovery space with what it calls a “chemistry-first” platform. Colorado-based Cime ...

Isomorphic Labs is the secretive AI life science startup spun out of Google DeepMind with the goal of solving all disease with AI-powered drug discovery.

The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development.

Schrödinger’s stock surged after the FDA's initiative to phase out animal testing, benefiting its computational drug ...

The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...